← All organizations

BeyondSpring Pharmaceuticals Inc.

For profitWebsite ↗

Also known as: BeyondSpring Pharmaceuticals Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2022

Timeline

2010s

Jun 1, 2014
BeyondSpring Pharmaceuticals Inc.— Founded

Drugs by trial phase (7 distinct, 8 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

pembrolizumab

Phase 1 (1 own, 0 via acquisition)

nivolumab

Indications

Studied for

Recent trials (8)

NCT05599789CollaboratorPhase 2Nov 1, 2022
NCT05130827CollaboratorPhase 2Nov 30, 2021
NCT03294577Lead sponsorPhase 2/Phase 3Nov 27, 2017
NCT04227990Lead sponsorPhase 2Nov 27, 2017
NCT04345900Lead sponsorPhase 2Apr 5, 2017
NCT03102606Lead sponsorPhase 2/Phase 3Mar 13, 2017
NCT02812667CollaboratorPhase 1Aug 1, 2016
NCT02504489Lead sponsorPhase 3Jun 1, 2016

Details

Founded: New York, NY, US Jun 1, 2014
Last known activity: Nov 1, 2022